Skip to main content
Top
Published in: Cancer Causes & Control 1/2014

01-01-2014 | Original paper

Using a composite index of socioeconomic status to investigate health disparities while protecting the confidentiality of cancer registry data

Authors: Mandi Yu, Zaria Tatalovich, James T. Gibson, Kathleen A. Cronin

Published in: Cancer Causes & Control | Issue 1/2014

Login to get access

Abstract

Purpose

The lack of individual socioeconomic status (SES) information in cancer registry data necessitates the use of area-based measures to investigate health disparities. Concerns about confidentiality, however, prohibit publishing patients’ residential locations at the subcounty level. We developed a census tract-based composite SES index to be released in place of individual census tracts to minimize the risk of disclosure.

Methods

Two SES indices based on the measures identified in the literature were constructed using factor analysis. The analyses were repeated using the data from the 2000 decennial census and 2005–2009 American Community Survey to create the indices at two time points, which were linked to 2000–2009 Surveillance, Epidemiology, and End Results registry data to estimate incidence and survival rates.

Results

The two indices performed similarly in stratifying census tracts and detecting socioeconomic gradients in cancer incidence and survival. The gradient in the incidence is positive for breast and prostate, and negative for lung cancers, in all races, although the level varies. The positive gradient in survival is more salient for regional-staged breast, colorectal, and lung cancers.

Conclusions

The census tract-based SES index provides a valuable tool for monitoring the disparities in cancer burdens while avoiding potential identity disclosure. This index, divided into tertiles and quintiles, is now available to the researchers on request.
Appendix
Available only for authorised users
Literature
1.
go back to reference Clegg LX, Reichman M, Miller BA, Hankey B, Singh G, Lin Y, Goodman M, Lynch C, Schwartz S, Chen V, Bernstein L, Gomez S, Graff J, Lin C, Johnson N, Edwards B (2009) Impact of socioeconomic status on cancer incidence and stage at diagnosis: selected findings from the surveillance, epidemiology, and end results: National Longitudinal Mortality Study. Cancer Causes Control 20(4):417–435PubMedCentralPubMedCrossRef Clegg LX, Reichman M, Miller BA, Hankey B, Singh G, Lin Y, Goodman M, Lynch C, Schwartz S, Chen V, Bernstein L, Gomez S, Graff J, Lin C, Johnson N, Edwards B (2009) Impact of socioeconomic status on cancer incidence and stage at diagnosis: selected findings from the surveillance, epidemiology, and end results: National Longitudinal Mortality Study. Cancer Causes Control 20(4):417–435PubMedCentralPubMedCrossRef
2.
go back to reference Devesa SS, Diamond EL (1983) Socioeconomic and racial differences in lung cancer incidence. Am J Epidemiol 118(6):818–831PubMed Devesa SS, Diamond EL (1983) Socioeconomic and racial differences in lung cancer incidence. Am J Epidemiol 118(6):818–831PubMed
3.
go back to reference Krieger N, Chen JT, Waterman PD, Soobader M-J, Subramanian SV, Carson R (2002) Geocoding and monitoring of US socioeconomic inequalities in mortality and cancer incidence: does the choice of area-based measure and geographic level matter? Am J Epidemiol 156(5):471–482. doi:10.1093/aje/kwf068 PubMedCrossRef Krieger N, Chen JT, Waterman PD, Soobader M-J, Subramanian SV, Carson R (2002) Geocoding and monitoring of US socioeconomic inequalities in mortality and cancer incidence: does the choice of area-based measure and geographic level matter? Am J Epidemiol 156(5):471–482. doi:10.​1093/​aje/​kwf068 PubMedCrossRef
4.
go back to reference Pugh H, Power C, Goldblatt P, Arber S (1991) Women’s lung cancer mortality, socio-economic status and changing smoking patterns. Soc Sci Med 32(10):1105–1110PubMedCrossRef Pugh H, Power C, Goldblatt P, Arber S (1991) Women’s lung cancer mortality, socio-economic status and changing smoking patterns. Soc Sci Med 32(10):1105–1110PubMedCrossRef
5.
go back to reference Ward EJA, Cokkinides V, Singh GK, Cardinez C, Ghafoor A, Thun M (2004) Cancer disparities by race/ethnicity and socioeconomic status. CA Cancer J Clin 54(2):78–93PubMedCrossRef Ward EJA, Cokkinides V, Singh GK, Cardinez C, Ghafoor A, Thun M (2004) Cancer disparities by race/ethnicity and socioeconomic status. CA Cancer J Clin 54(2):78–93PubMedCrossRef
7.
go back to reference Dutton DB, Levine S (1989) Overview, methodological critique, and reformulation. In: Bunker JP, Gomby DS, Kehrer BH (eds) Pathways to health. The Henry J. Kaiser Family Foundation, Menlo Park, CA Dutton DB, Levine S (1989) Overview, methodological critique, and reformulation. In: Bunker JP, Gomby DS, Kehrer BH (eds) Pathways to health. The Henry J. Kaiser Family Foundation, Menlo Park, CA
9.
go back to reference Witkowski KM (2008) Disclosure risk components of contextualized microdata: identifying unique geographic units and the implications for pinpointing survey respondents. ICPSR working paper series. University of Michigan, Ann Arbor Witkowski KM (2008) Disclosure risk components of contextualized microdata: identifying unique geographic units and the implications for pinpointing survey respondents. ICPSR working paper series. University of Michigan, Ann Arbor
10.
go back to reference Robert SA, House JS (2000) Socioeconomic inequalities in health: an enduring sociological problem. In: Bird CE, Conrad P, Fremont AM (eds) Handbook of medical sociology. Prentice Hall, Upper Saddle River, NJ, pp 79–97 Robert SA, House JS (2000) Socioeconomic inequalities in health: an enduring sociological problem. In: Bird CE, Conrad P, Fremont AM (eds) Handbook of medical sociology. Prentice Hall, Upper Saddle River, NJ, pp 79–97
11.
go back to reference Gornick ME (2002) Measuring the effects of socioeconomic status on health care. In: Swift EK (ed) Guidance for the National Healthcare Disparities Report. Institute of Medicine of the National Academies, Washington, DC, pp 45–74 Gornick ME (2002) Measuring the effects of socioeconomic status on health care. In: Swift EK (ed) Guidance for the National Healthcare Disparities Report. Institute of Medicine of the National Academies, Washington, DC, pp 45–74
12.
go back to reference Griffin DH, Love SP, Obenski SM (2003) Can the American Community Survey replace the census long form? In: American association for public opinion research. Nashville, TN, pp 94–99 Griffin DH, Love SP, Obenski SM (2003) Can the American Community Survey replace the census long form? In: American association for public opinion research. Nashville, TN, pp 94–99
14.
go back to reference Frey W, Singer A (2006) Katrina and Rita impacts on gulf coast populations: first census findings. Brookings Institution, Washington, DC Frey W, Singer A (2006) Katrina and Rita impacts on gulf coast populations: first census findings. Brookings Institution, Washington, DC
15.
go back to reference Conover WJ, Iman RL (1981) Rank transformations as a bridge between parametric and nonparametric statistics. Am Stat 35(3):124–129 Conover WJ, Iman RL (1981) Rank transformations as a bridge between parametric and nonparametric statistics. Am Stat 35(3):124–129
16.
go back to reference Ingram DD, Parker JD, Schenker N, Weed JA, Hamilton B, Arias E, Madans JH (2003) United States Census 2000 population with bridged race categories. Vital Health Stat Ser 2 135:1–55 Ingram DD, Parker JD, Schenker N, Weed JA, Hamilton B, Arias E, Madans JH (2003) United States Census 2000 population with bridged race categories. Vital Health Stat Ser 2 135:1–55
17.
go back to reference Howlader N, Noone A, Krapcho M, Neyman N, Aminou R, Waldron W, Altekruse S, Kosary C, Ruhl J, Tatalovich Z, Cho H, Mariotto A, Eisner M, Lewis D, Chen H, Feuer E, Cronin K, Edwards Be (2011) SEER cancer statistics review, 1975–2008, based on November 2010 SEER data submission, posted to the SEER web site, 2011. National Cancer Institute, Bethesda, MD. http://seer.cancer.gov/csr/1975_2008/ Howlader N, Noone A, Krapcho M, Neyman N, Aminou R, Waldron W, Altekruse S, Kosary C, Ruhl J, Tatalovich Z, Cho H, Mariotto A, Eisner M, Lewis D, Chen H, Feuer E, Cronin K, Edwards Be (2011) SEER cancer statistics review, 1975–2008, based on November 2010 SEER data submission, posted to the SEER web site, 2011. National Cancer Institute, Bethesda, MD. http://​seer.​cancer.​gov/​csr/​1975_​2008/​
18.
go back to reference Howlader N, Ries LA, Mariotto AB, Reichman ME, Ruhl J, Cronin KA (2010) Improved estimates of cancer-specific survival rates from population-based data. J Natl Cancer Inst 102(20):1584–1598PubMedCrossRef Howlader N, Ries LA, Mariotto AB, Reichman ME, Ruhl J, Cronin KA (2010) Improved estimates of cancer-specific survival rates from population-based data. J Natl Cancer Inst 102(20):1584–1598PubMedCrossRef
19.
go back to reference Kvåle R, Auvinen A, Adami H-O, Klint Å, Hernes E, Møller B, Pukkala E, Storm HH, Tryggvadottir L, Tretli S, Wahlqvist R, Weiderpass E, Bray F (2007) Interpreting trends in prostate cancer incidence and mortality in the five Nordic countries. J Natl Cancer Inst 99(24):1881–1887. doi:10.1093/jnci/djm249 PubMedCrossRef Kvåle R, Auvinen A, Adami H-O, Klint Å, Hernes E, Møller B, Pukkala E, Storm HH, Tryggvadottir L, Tretli S, Wahlqvist R, Weiderpass E, Bray F (2007) Interpreting trends in prostate cancer incidence and mortality in the five Nordic countries. J Natl Cancer Inst 99(24):1881–1887. doi:10.​1093/​jnci/​djm249 PubMedCrossRef
20.
go back to reference Draisma G, Boer R, Otto SJ, van der Cruijsen IW, Damhuis RAM, Schröder FH, de Koning HJ (2003) Lead times and overdetection due to prostate-specific antigen screening: estimates from the European randomized study of screening for prostate cancer. J Natl Cancer Inst 95(12):868–878. doi:10.1093/jnci/95.12.868 PubMedCrossRef Draisma G, Boer R, Otto SJ, van der Cruijsen IW, Damhuis RAM, Schröder FH, de Koning HJ (2003) Lead times and overdetection due to prostate-specific antigen screening: estimates from the European randomized study of screening for prostate cancer. J Natl Cancer Inst 95(12):868–878. doi:10.​1093/​jnci/​95.​12.​868 PubMedCrossRef
21.
go back to reference Winawer SJ ZA, Ho MN, O’Brien MJ, Gottlieb LS, Sternberg SS, Waye JD, Schapiro M, Bond JH, Panish JF, Ackroyd F, Shike M, Kurtz RC, Hornsby-Lewis L, Gerdes H, Stewart ET (1993) Prevention of colorectal cancer by colonoscopic polypectomy. New Engl J Med 329(27). doi:10.1056/NEJM199312303292701 Winawer SJ ZA, Ho MN, O’Brien MJ, Gottlieb LS, Sternberg SS, Waye JD, Schapiro M, Bond JH, Panish JF, Ackroyd F, Shike M, Kurtz RC, Hornsby-Lewis L, Gerdes H, Stewart ET (1993) Prevention of colorectal cancer by colonoscopic polypectomy. New Engl J Med 329(27). doi:10.​1056/​NEJM199312303292​701
Metadata
Title
Using a composite index of socioeconomic status to investigate health disparities while protecting the confidentiality of cancer registry data
Authors
Mandi Yu
Zaria Tatalovich
James T. Gibson
Kathleen A. Cronin
Publication date
01-01-2014
Publisher
Springer Netherlands
Published in
Cancer Causes & Control / Issue 1/2014
Print ISSN: 0957-5243
Electronic ISSN: 1573-7225
DOI
https://doi.org/10.1007/s10552-013-0310-1

Other articles of this Issue 1/2014

Cancer Causes & Control 1/2014 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine